PHEXXI

Peak

lactic acid, l-, citric acid monohydrate, and potassium bitartrate

NDAVAGINALGEL
Approved
May 2020
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
1

Mechanism of Action

studies, Phexxi produced a normal vaginal pH range (pH 3.5 – 4.5) in the presence of semen. In clinical studies, post-coital testing demonstrated pH < 5 in the majority of subjects, and sperm motility reduction.

Clinical Trials (1)

NCT01306331Phase 3Completed

Study of Contraceptive Efficacy & Safety of Phexxi™ (Previously Known as Amphora) Gel Compared to Conceptrol Vaginal Gel

Started Apr 2011

Loss of Exclusivity

LOE Date
Mar 15, 2033
85 months away
Patent Expiry
Mar 15, 2033

Patent Records (4)

Patent #ExpiryTypeUse Code
10568855
Mar 15, 2033
U-1
11337989
Mar 15, 2033
U-1
11439610
Mar 15, 2033
SubstanceProduct
11992472
Mar 15, 2033
U-1